<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cancers (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Cancers (Basel)</journal-id><journal-id journal-id-type="publisher-id">cancers</journal-id><journal-title-group><journal-title>Cancers</journal-title></journal-title-group><issn pub-type="epub">2072-6694</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26473929</article-id><article-id pub-id-type="pmc">4695876</article-id><article-id pub-id-type="doi">10.3390/cancers7040876</article-id><article-id pub-id-type="publisher-id">cancers-07-00876</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Direct Interaction between Carcinoma Cells and Cancer Associated Fibroblasts for the Regulation of Cancer Invasion</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Yamaguchi</surname><given-names>Hideki</given-names></name><xref ref-type="aff" rid="af1-cancers-07-00876">1</xref></contrib><contrib contrib-type="author"><name><surname>Sakai</surname><given-names>Ryuichi</given-names></name><xref ref-type="aff" rid="af1-cancers-07-00876">1</xref><xref ref-type="aff" rid="af2-cancers-07-00876">2</xref><xref rid="c1-cancers-07-00876" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Lin</surname><given-names>Huey-Jen</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-cancers-07-00876"><label>1</label>Division of Refractory and Advanced Cancer, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan; <email>hidyamag@ncc.go.jp</email></aff><aff id="af2-cancers-07-00876"><label>2</label>Department of Biochemistry, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa 252-0374, Japan</aff><author-notes><corresp id="c1-cancers-07-00876"><label>*</label>Correspondence: <email>rsakai@ncc.go.jp</email>; Tel.: +81-3-3542-2511 (ext. 4300); Fax: +81-3-3542-8170</corresp></author-notes><pub-date pub-type="epub"><day>14</day><month>10</month><year>2015</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2015</year></pub-date><volume>7</volume><issue>4</issue><fpage>2054</fpage><lpage>2062</lpage><history><date date-type="received"><day>02</day><month>9</month><year>2015</year></date><date date-type="accepted"><day>12</day><month>10</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; 2015 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement><copyright-year>2015</copyright-year><license><license-p><!--CREATIVE COMMONS-->This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>The tumor stroma acts as an essential microenvironment of the cancer cells, which includes many different types of non-cancerous cells and the extracellular matrix (ECM). Stromal fibroblasts (SFs) are the major cellular constituents of the tumor stroma and are often called cancer-associated fibroblasts (CAFs). They are often characterized by &#x003b1;-smooth muscle actin (&#x003b1;SMA) expression, which is indicative of the myofibroblast phenotype and strong contractility. These characteristics contribute to the remodeling and stiffening of the stromal ECM, thereby offering an appropriate field for cancer cell invasion. Importance of the tumor stroma in cancer progression has recently been highlighted. Moreover, several reports suggest that stromal fibroblasts interact with adjacent cancer cells through soluble factors, exosomes, or direct cell-cell adhesion to promote cancer cell invasion. In this review, current models of the regulation of cancer cell invasion by surrounding fibroblasts are summarized, including our recent work on the interaction between stromal fibroblasts and scirrhous gastric carcinoma (SGC) cells by using a three-dimensional (3D) culture system. Further mechanistic insights into the roles of the interaction between cancer cells and stromal fibroblasts in cancer invasion will be required to identify novel molecular targets for preventing cancer cell invasion.</p></abstract><kwd-group><kwd>cancer-associated fibroblasts</kwd><kwd>cancer invasion</kwd><kwd>scirrhous gastric carcinoma</kwd><kwd>peritoneal dissemination</kwd></kwd-group></article-meta></front><body><sec id="sec1-cancers-07-00876"><title>1. Introduction</title><p>Tumor tissues contain not only cancer cells but also other cellular and non-cellular components. Cellular components of a tumor microenvironment include fibroblasts, immune cells, endothelial cells, mesenchymal stem cells, while non-cellular components include extracellular matrix and deposited growth factors and signaling molecules. These tumor stroma components that surround the cancer cells create the so-called tumor microenvironment that supports the malignant aspects of cancer cells [<xref rid="B1-cancers-07-00876" ref-type="bibr">1</xref>,<xref rid="B2-cancers-07-00876" ref-type="bibr">2</xref>,<xref rid="B3-cancers-07-00876" ref-type="bibr">3</xref>,<xref rid="B4-cancers-07-00876" ref-type="bibr">4</xref>,<xref rid="B5-cancers-07-00876" ref-type="bibr">5</xref>,<xref rid="B6-cancers-07-00876" ref-type="bibr">6</xref>].</p><p>Cancer-associated fibroblasts (CAF) comprise a major part of the cellular components of the tumor microenvironment [<xref rid="B7-cancers-07-00876" ref-type="bibr">7</xref>,<xref rid="B8-cancers-07-00876" ref-type="bibr">8</xref>,<xref rid="B9-cancers-07-00876" ref-type="bibr">9</xref>]. CAFs seem to be derived from resident stromal fibroblasts and fibroblast-like cells, such as hepatic and pancreatic stellate cells, and circulating bone marrow-derived cells. Moreover, it is also proposed that epithelial, endothelial, and smooth muscle cells transdifferentiate into CAFs [<xref rid="B10-cancers-07-00876" ref-type="bibr">10</xref>,<xref rid="B11-cancers-07-00876" ref-type="bibr">11</xref>]. Cancer cells induce the conversion of these various types of cells into CAFs. Through the so-called &#x0201c;education&#x0201d; by cancer cells, CAFs acquire the properties of myofibroblasts including expression of smooth muscle alpha-actin (SMA) and strong contractility [<xref rid="B12-cancers-07-00876" ref-type="bibr">12</xref>,<xref rid="B13-cancers-07-00876" ref-type="bibr">13</xref>]. CAFs secrete several signaling molecules to stimulate cancer cells and other cell types in tumor microenvironments [<xref rid="B14-cancers-07-00876" ref-type="bibr">14</xref>] and remodel the extracellular matrix by secreting ECM components and matrix-degrading enzymes and by physically contracting matrix [<xref rid="B12-cancers-07-00876" ref-type="bibr">12</xref>,<xref rid="B15-cancers-07-00876" ref-type="bibr">15</xref>]. These properties of CAFs support the malignant progression of tumors by promoting growth, survival, angiogenesis, inflammation, drug resistance, and invasion and metastasis of tumors.</p><p>In this review, we would like to focus on the role of CAFs in promoting cancer cell invasion with a particular interest in the direct interaction between CAFs and cancer cells. We also discuss possible strategies to target the interaction between CAFs and cancer cells for the development of new cancer therapeutics.</p></sec><sec id="sec2-cancers-07-00876"><title>2. CAFs Create Favorable Microenvironments for Carcinoma Cell Invasion</title><p>Cancer cell invasion into the surrounding normal tissues is a prerequisite for distant metastasis and is initiated by the detachment of cancer cells from the primary tumor [<xref rid="B16-cancers-07-00876" ref-type="bibr">16</xref>,<xref rid="B17-cancers-07-00876" ref-type="bibr">17</xref>]. This requires the loss of cell-cell adhesion, breakdown of the basement membrane surrounding the tumor tissues, and cell migration into the tumor stroma [<xref rid="B18-cancers-07-00876" ref-type="bibr">18</xref>,<xref rid="B19-cancers-07-00876" ref-type="bibr">19</xref>,<xref rid="B20-cancers-07-00876" ref-type="bibr">20</xref>]. Phenotypic changes that confer these capabilities on cancer cells are largely induced by epithelial-mesenchymal transition (EMT) [<xref rid="B21-cancers-07-00876" ref-type="bibr">21</xref>]. EMT causes the loss of E-cadherin expression, the increase in matrix metalloproteinase production, and the activation of cellular machinery for cell migration.</p><p>CAFs secrete soluble factors, including TGF-&#x003b2; and HGF, which promote EMT of the neighboring cancer cells via paracrine signaling [<xref rid="B22-cancers-07-00876" ref-type="bibr">22</xref>]. Apart from the soluble factors, exosomes mediate the transfer of functional molecules from CAFs to cancer cells, which stimulate the invasive and metastatic potencies of cancer cells [<xref rid="B23-cancers-07-00876" ref-type="bibr">23</xref>,<xref rid="B24-cancers-07-00876" ref-type="bibr">24</xref>]. CAFs also secrete matrix-degrading enzymes such as matrix metalloproteinases (MMPs) for ECM degradation. MMPs, which are activated on the invasive front of cancer cells, cleave ECM components within the basement membrane and tumor stroma to generate paths for cancer cell invasion [<xref rid="B18-cancers-07-00876" ref-type="bibr">18</xref>]. Cleavage of ECM components also releases latent growth factors in the ECM that in turn promote cancer cell invasion. Invadopodia are actin-rich membrane protrusions formed by invasive cells that focalize MMP activity to the site of ECM degradation [<xref rid="B25-cancers-07-00876" ref-type="bibr">25</xref>]. Goicoechea <italic>et al.</italic> recently reported that an actin-binding protein palladin promotes invasion of cancer cells by enhancing invadopodia formation in CAFs [<xref rid="B26-cancers-07-00876" ref-type="bibr">26</xref>].</p><p>Matrix stiffening in the tumor microenvironment enhances cancer cell migration and invasion through integrin-mediated mechanotransduction [<xref rid="B27-cancers-07-00876" ref-type="bibr">27</xref>,<xref rid="B28-cancers-07-00876" ref-type="bibr">28</xref>,<xref rid="B29-cancers-07-00876" ref-type="bibr">29</xref>]. CAFs also contribute to matrix stiffening by secreting ECM components and by directly and mechanically contracting ECM through actomyosin contractility [<xref rid="B15-cancers-07-00876" ref-type="bibr">15</xref>]. Recent studies showed that the functions of Cav1 and YAP in CAFs are required for matrix stiffening, which in turn induces cancer cell invasion [<xref rid="B30-cancers-07-00876" ref-type="bibr">30</xref>,<xref rid="B31-cancers-07-00876" ref-type="bibr">31</xref>].</p></sec><sec id="sec3-cancers-07-00876"><title>3. Direct Interaction between CAFs and Carcinoma Cells Controls Invasion</title><p>In addition to paracrine communication via soluble factors and exosomes, accumulating evidence highlights the importance of direct physical interactions between CAFs and cancer cells for enhancement of cancer cell invasion (<xref ref-type="fig" rid="cancers-07-00876-f001">Figure 1</xref>). An important study by Gaggioli <italic>et al.</italic> showed that CAFs lead the invasion of squamous cell carcinoma (SCC) cells by generating tracks in the ECM matrix in a three-dimensional (3D) co-culture system [<xref rid="B32-cancers-07-00876" ref-type="bibr">32</xref>]. Direct observation of the invading cells revealed that the leading cells are always CAFs and that SCC cells associate with and follow CAFs to co-invade as collective chains. Importantly, a conditioned medium of CAFs was not able to enhance cancer cell invasion. Furthermore, separation of the two cell types with a thin matrix markedly blocked co-invasion. These observations suggest that close proximity, and probably direct contact, between CAFs and SCC cells is required for SCC cell invasion. More recently, Otomo <italic>et al.</italic> demonstrated that p53-depleted CAFs enhanced invasion of lung carcinoma cells in a 3D co-culture system and that this process also requires direct contact between the two cell types [<xref rid="B33-cancers-07-00876" ref-type="bibr">33</xref>].</p><fig id="cancers-07-00876-f001" position="float"><label>Figure 1</label><caption><p>Direct interaction between cancer-associated fibroblasts (CAFs) and cancer cells promotes cancer cell invasion. CAFs and SGC cells indirectly interact via paracrine signaling mediated by soluble factors and exosomes. This interaction induces phenotypic changes in both the cell types, which in turn trigger cancer cell invasion. Through paracrine signaling, the two cell types attract each other, leading to a direct physical interaction that may be mediated by cell-surface adhesion molecules. This direct interaction may cause further changes in both cell types, resulting in a more efficient CAF-led cancer cell invasion.</p></caption><graphic xlink:href="cancers-07-00876-g001"/></fig><p>Scirrhous gastric carcinoma (SGC), a subtype of diffuse-type gastric adenocarcinoma, has a very poor prognosis [<xref rid="B34-cancers-07-00876" ref-type="bibr">34</xref>,<xref rid="B35-cancers-07-00876" ref-type="bibr">35</xref>]. SGC is characterized by rapid and diffusive invasion under the submucosa, strong fibrosis associated with massive growth of fibroblasts, and frequent peritoneal dissemination. CAFs have been shown to promote the aggressive phenotypes of SGC cells [<xref rid="B36-cancers-07-00876" ref-type="bibr">36</xref>], which includes growth and tumorigenicity [<xref rid="B37-cancers-07-00876" ref-type="bibr">37</xref>], migration and invasion [<xref rid="B38-cancers-07-00876" ref-type="bibr">38</xref>,<xref rid="B39-cancers-07-00876" ref-type="bibr">39</xref>], adhesion to mesothelial cells [<xref rid="B40-cancers-07-00876" ref-type="bibr">40</xref>], peritoneal dissemination [<xref rid="B41-cancers-07-00876" ref-type="bibr">41</xref>,<xref rid="B42-cancers-07-00876" ref-type="bibr">42</xref>], and stemness [<xref rid="B43-cancers-07-00876" ref-type="bibr">43</xref>]. Conversely, SGC cells stimulate the growth of CAFs [<xref rid="B44-cancers-07-00876" ref-type="bibr">44</xref>] and induce contraction of CAFs, leading to matrix stiffening [<xref rid="B45-cancers-07-00876" ref-type="bibr">45</xref>]. These reports attribute the communication between CAFs and SGC cells to paracrine signaling. Nevertheless, Semba <italic>et al.</italic> showed that the direct interaction between stromal fibroblasts and SGC cells is required for induction of fibroblast proliferation and for the development of invasive phenotypes in SGC cells [<xref rid="B38-cancers-07-00876" ref-type="bibr">38</xref>].</p><p>We recently reported that co-culturing SGC cells and CAFs derived from SGC tissues on 3D Matrigel induce formation of foci that contain the two cell types in close contact and invade the Matrigel [<xref rid="B46-cancers-07-00876" ref-type="bibr">46</xref>] (<xref ref-type="fig" rid="cancers-07-00876-f002">Figure 2</xref>A,B). CAFs localized at the center and the leading front of the invasive foci and the associated SGC cells co-invaded the underlying matrix. Interestingly, SGC cells alone did not show a strong invasive phenotype. Satoyoshi <italic>et al.</italic> recently reported similar observations that CAFs lead and co-invade with SGC cells in a 3D co-culture system and <italic>in vivo</italic> [<xref rid="B47-cancers-07-00876" ref-type="bibr">47</xref>]. This phenomenon was not recapitulated by the addition of a conditioned medium of CAFs to SGC cells, or <italic>vice versa</italic>, indicating the importance of a direct interaction between the two cell types. Indeed, time-lapse imaging of the invasive process revealed that both cells attract each other and extend long protrusions through which they subsequently associate. Additionally, direct interaction between the two cell types through filopodia and lamellipodia-like structures was observed in 2D co-culture (<xref ref-type="fig" rid="cancers-07-00876-f002">Figure 2</xref>C).</p><fig id="cancers-07-00876-f002" position="float"><label>Figure 2</label><caption><p>Direct interaction between cancer-associated fibroblasts (CAFs) and scirrhous gastric carcinoma (SGC) cells. (<bold>A</bold>) CAFs and SGC cells cultured at the top of the 3D Matrigel form invasive foci. SGC cells come in contact with CAFs and co-invade the 3D Matrigel; (<bold>B</bold>) F-actin staining of the invasive foci consisting of CAFs and SGC cells showed that the foci invade the Matrigel and are associated with cleaved signals for collagen type IV; (<bold>C</bold>) CAFs expressing fibronectin (white arrowheads) physically associate with SGC cells by extending their lamellipodia and filopodia toward SGC cells (yellow arrowheads). The lower panels show magnified images of the boxed regions; (<bold>D</bold>) Treatment with an Src inhibitor dasatinib blocks the interaction between CAFs and SGC cells, resulting in the suppression of invasive foci formation and invasion. (<bold>A</bold> and <bold>D</bold>) Images are reproduced from Yamaguchi <italic>et al.</italic> [<xref rid="B46-cancers-07-00876" ref-type="bibr">46</xref>].</p></caption><graphic xlink:href="cancers-07-00876-g002"/></fig><p>We also showed that direct interaction with SGC cells promotes the ability of CAFs to remodel and mechanically disrupt the ECM matrix through an increase in actomyosin contractility. These observations show that SGC cells directly interact with CAFs and promote their ability to mechanically remodel the ECM matrix for invasion. As strong fibrosis and contraction of the stomach wall occur during SGC progression, the matrix remodeling activity of CAFs stimulated by SGC cells may contribute to the pathological features of SGC.</p><p>The molecular mechanisms by which the direct physical interaction between CAFs and cancer cells stimulates cancer cell invasion remain poorly understood. It was reported that CAFs enhance EMT and cell migration of non-small cell lung cancer (LSCLC) cells more potently through direct contacts rather than through indirect interactions [<xref rid="B48-cancers-07-00876" ref-type="bibr">48</xref>]. Gene expression of breast cancer cells that are in direct contact with CAFs markedly differ from that observed in cells that indirectly interact with CAFs through soluble factors [<xref rid="B49-cancers-07-00876" ref-type="bibr">49</xref>]. Therefore, direct contact between the two cell types may elicit specific changes in gene expression that induce EMT and confer the migratory phenotype on the cancer cells.</p><p>Cancer cells that have undergone EMT acquire stem cell-like traits and have a propensity to invade [<xref rid="B21-cancers-07-00876" ref-type="bibr">21</xref>]. Kinugasa <italic>et al.</italic> reported that CAFs sustain the stemness of colorectal cancer stem cells, which requires direct cell-cell contact between CAFs and cancer stem cells and CD44 expression in CAFs [<xref rid="B50-cancers-07-00876" ref-type="bibr">50</xref>]. It is unclear whether CD44 is involved in the direct interaction or whether it just participates in maintaining stemness. Although this study did not examine the invasiveness of cancer cells, the induction of stemness by CAFs through direct interactions may be associated with increased invasive potencies.</p><p>An interesting study showed that a conditioned medium of co-cultured stromal fibroblasts and breast cancer cells increases migration, invasion, and metastasis of cancer cells, whereas that of homotypic cultures had little effect on these cancer progression-associated properties [<xref rid="B51-cancers-07-00876" ref-type="bibr">51</xref>]. Surprisingly, this effect of co-cultured conditioned medium can be induced by transient treatment of cancer cells and is mediated by a TGF-&#x003b2; mediated mechanism. This observation suggests that the direct interaction also affects paracrine signaling between CAFs and cancer cells.</p></sec><sec id="sec4-cancers-07-00876"><title>4. Targeting the Interaction between CAFs and Carcinoma Cells</title><p>Several studies corroborated the therapeutic potential of targeting tumor progression-supporting functions of CAFs [<xref rid="B52-cancers-07-00876" ref-type="bibr">52</xref>,<xref rid="B53-cancers-07-00876" ref-type="bibr">53</xref>]. For example, targeting CAFs themselves by eliminating FAP-positive CAFs in mouse models suppressed tumor growth in lung and pancreatic carcinomas [<xref rid="B54-cancers-07-00876" ref-type="bibr">54</xref>]. Several agents that have been tested in preclinical studies or clinical trials target the soluble mediators of the interactions between CAFs and cancer cells, including HGF, TGF-&#x003b2;, and CXCL12 [<xref rid="B52-cancers-07-00876" ref-type="bibr">52</xref>]. In the case of SGC, COX2 inhibitor was shown to block CAF-stimulated SGC invasion and metastasis [<xref rid="B55-cancers-07-00876" ref-type="bibr">55</xref>]. Pro-invasive functions of CAFs may also be targeted to block CAF-driven carcinoma cell invasion. Chemical screening of CAF contraction inhibitors identified lovastatin and simvastatin as inhibitors of CAF-stimulated SCC invasion [<xref rid="B56-cancers-07-00876" ref-type="bibr">56</xref>].</p><p>To identify inhibitors of the direct interaction between CAFs and cancer cells, we utilized the above-mentioned 3D co-culture system of CAFs and SGC cells for drug screening [<xref rid="B46-cancers-07-00876" ref-type="bibr">46</xref>]. Thus, we found that an Src inhibitor dasatinib effectively blocks the physical association between CAFs and SGC cells with minimal cytotoxic effect (<xref ref-type="fig" rid="cancers-07-00876-f002">Figure 2</xref>D). Dasatinib showed marked therapeutic potencies against peritoneal dissemination of SGC in mouse model experiments. Importantly, histological analysis revealed that metastasized tumors are less associated with stromal fibroblasts in mice treated with dasatinib as compared to that observed in control mice. These results demonstrate that the direct interaction between CAFs and SGC cells can be a target for anti-metastasis therapy.</p><p>When targeting CAFs, it should be considered that they may also play suppressive roles in tumor progression. Two recent studies demonstrated that depletion of CAFs in mouse models accelerates progression of pancreatic cancer [<xref rid="B57-cancers-07-00876" ref-type="bibr">57</xref>,<xref rid="B58-cancers-07-00876" ref-type="bibr">58</xref>]. These results contradict other studies [<xref rid="B54-cancers-07-00876" ref-type="bibr">54</xref>,<xref rid="B59-cancers-07-00876" ref-type="bibr">59</xref>,<xref rid="B60-cancers-07-00876" ref-type="bibr">60</xref>] and this discrepancy could be caused by the use of different animal models (e.g., genetically-engineered, human-to-mouse xenograft) or different approaches to deplete CAFs (e.g., depletion of FAP or &#x003b1;SMA positive cells, sonic hedgehog inhibition). Given the heterogeneous nature of CAFs [<xref rid="B9-cancers-07-00876" ref-type="bibr">9</xref>], it is also possible that their subpopulations have tumor-suppressive functions. Alternatively, their roles may differ between tumor types, stages, and genetic backgrounds. Further studies are needed to understand intra- and inter-tumoral heterogeneity of CAFs for the development of strategy to appropriately target tumor-promoting functions of CAFs.</p></sec><sec id="sec5-cancers-07-00876"><title>5. Conclusions and Perspectives</title><p>Over the last few decades, critical roles of CAFs in the promotion of cancer invasion have been well established. Extensive efforts have been made to understand the molecular mechanisms underlying the interaction between CAFs and cancer cells during cancer cell invasion. However, the importance of the direct interaction between the two cell types has emerged only in recent years; therefore, several questions remain to be answered. Probably, the most important challenge is to identify molecules that mediate the physical association of CAFs with cancer cells. As these molecules are supposed to be displayed on the cell surface, they are good targets for the development of new molecular targeted therapies. It is also important to identify signaling pathways and molecules in cancer cells that can be activated upon direct interaction with CAFs. Further analysis of gene expression profiles and activation statuses of signaling molecules and characterization of cellular structures mediating cell-cell adhesion may help identify molecules involved in cancer invasion promoted by the direct interaction between CAFs and cancer cells.</p></sec></body><back><ack><title>Acknowledgments</title><p>We gratefully acknowledge Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (Research Project Number: 26290043 to R.S. and 25430126 to H.Y.) and the National Cancer Center Research and Development Fund (23-A-9). This work was also supported in part by Daiichi Sankyo Foundation of Life Science.</p></ack><notes><title>Author Contributions</title><p>H.Y. and R.S. wrote the paper.</p></notes><notes><title>Conflicts of Interest</title><p>The authors declare that they have no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-cancers-07-00876"><label>1.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bissell</surname><given-names>M.J.</given-names></name><name><surname>Hines</surname><given-names>W.C.</given-names></name></person-group>
<article-title>Why don&#x02019;t we get more cancer? A proposed role of the microenvironment in restraining cancer progression</article-title>
<source>Nat. Med.</source>
<year>2011</year>
<volume>17</volume>
<fpage>320</fpage>
<lpage>329</lpage>
<pub-id pub-id-type="doi">10.1038/nm.2328</pub-id>
<pub-id pub-id-type="pmid">21383745</pub-id></element-citation></ref><ref id="B2-cancers-07-00876"><label>2.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hanahan</surname><given-names>D.</given-names></name><name><surname>Weinberg</surname><given-names>R.A.</given-names></name></person-group>
<article-title>Hallmarks of cancer: The next generation</article-title>
<source>Cell</source>
<year>2011</year>
<volume>144</volume>
<fpage>646</fpage>
<lpage>674</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2011.02.013</pub-id>
<pub-id pub-id-type="pmid">21376230</pub-id></element-citation></ref><ref id="B3-cancers-07-00876"><label>3.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Joyce</surname><given-names>J.A.</given-names></name><name><surname>Pollard</surname><given-names>J.W.</given-names></name></person-group>
<article-title>Microenvironmental regulation of metastasis</article-title>
<source>Nat. Rev. Cancer</source>
<year>2009</year>
<volume>9</volume>
<fpage>239</fpage>
<lpage>252</lpage>
<pub-id pub-id-type="doi">10.1038/nrc2618</pub-id>
<pub-id pub-id-type="pmid">19279573</pub-id></element-citation></ref><ref id="B4-cancers-07-00876"><label>4.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Junttila</surname><given-names>M.R.</given-names></name><name><surname>de Sauvage</surname><given-names>F.J.</given-names></name></person-group>
<article-title>Influence of tumour micro-environment heterogeneity on therapeutic response</article-title>
<source>Nature</source>
<year>2013</year>
<volume>501</volume>
<fpage>346</fpage>
<lpage>354</lpage>
<pub-id pub-id-type="doi">10.1038/nature12626</pub-id>
<pub-id pub-id-type="pmid">24048067</pub-id></element-citation></ref><ref id="B5-cancers-07-00876"><label>5.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Klemm</surname><given-names>F.</given-names></name><name><surname>Joyce</surname><given-names>J.A.</given-names></name></person-group>
<article-title>Microenvironmental regulation of therapeutic response in cancer</article-title>
<source>Trends Cell Biol.</source>
<year>2015</year>
<volume>25</volume>
<fpage>198</fpage>
<lpage>213</lpage>
<pub-id pub-id-type="doi">10.1016/j.tcb.2014.11.006</pub-id>
<pub-id pub-id-type="pmid">25540894</pub-id></element-citation></ref><ref id="B6-cancers-07-00876"><label>6.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Quail</surname><given-names>D.F.</given-names></name><name><surname>Joyce</surname><given-names>J.A.</given-names></name></person-group>
<article-title>Microenvironmental regulation of tumor progression and metastasis</article-title>
<source>Nat. Med.</source>
<year>2013</year>
<volume>19</volume>
<fpage>1423</fpage>
<lpage>1437</lpage>
<pub-id pub-id-type="doi">10.1038/nm.3394</pub-id>
<pub-id pub-id-type="pmid">24202395</pub-id></element-citation></ref><ref id="B7-cancers-07-00876"><label>7.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bhowmick</surname><given-names>N.A.</given-names></name><name><surname>Neilson</surname><given-names>E.G.</given-names></name><name><surname>Moses</surname><given-names>H.L.</given-names></name></person-group>
<article-title>Stromal fibroblasts in cancer initiation and progression</article-title>
<source>Nature</source>
<year>2004</year>
<volume>432</volume>
<fpage>332</fpage>
<lpage>337</lpage>
<pub-id pub-id-type="doi">10.1038/nature03096</pub-id>
<pub-id pub-id-type="pmid">15549095</pub-id></element-citation></ref><ref id="B8-cancers-07-00876"><label>8.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kalluri</surname><given-names>R.</given-names></name><name><surname>Zeisberg</surname><given-names>M.</given-names></name></person-group>
<article-title>Fibroblasts in cancer</article-title>
<source>Nat. Rev. Cancer</source>
<year>2006</year>
<volume>6</volume>
<fpage>392</fpage>
<lpage>401</lpage>
<pub-id pub-id-type="doi">10.1038/nrc1877</pub-id>
<pub-id pub-id-type="pmid">16572188</pub-id></element-citation></ref><ref id="B9-cancers-07-00876"><label>9.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ohlund</surname><given-names>D.</given-names></name><name><surname>Elyada</surname><given-names>E.</given-names></name><name><surname>Tuveson</surname><given-names>D.</given-names></name></person-group>
<article-title>Fibroblast heterogeneity in the cancer wound</article-title>
<source>J. Exp. Med.</source>
<year>2014</year>
<volume>211</volume>
<fpage>1503</fpage>
<lpage>1523</lpage>
<pub-id pub-id-type="pmid">25071162</pub-id></element-citation></ref><ref id="B10-cancers-07-00876"><label>10.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xing</surname><given-names>F.</given-names></name><name><surname>Saidou</surname><given-names>J.</given-names></name><name><surname>Watabe</surname><given-names>K.</given-names></name></person-group>
<article-title>Cancer associated fibroblasts (CAFs) in tumor microenvironment</article-title>
<source>Front. Biosci. (Landmark Ed.)</source>
<year>2010</year>
<volume>15</volume>
<fpage>166</fpage>
<lpage>179</lpage>
<pub-id pub-id-type="doi">10.2741/3613</pub-id>
<pub-id pub-id-type="pmid">20036813</pub-id></element-citation></ref><ref id="B11-cancers-07-00876"><label>11.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Madar</surname><given-names>S.</given-names></name><name><surname>Goldstein</surname><given-names>I.</given-names></name><name><surname>Rotter</surname><given-names>V.</given-names></name></person-group>
<article-title>&#x02018;Cancer associated fibroblasts&#x02019;&#x02014;More than meets the eye</article-title>
<source>Trends Mol. Med.</source>
<year>2013</year>
<volume>19</volume>
<fpage>447</fpage>
<lpage>453</lpage>
<pub-id pub-id-type="doi">10.1016/j.molmed.2013.05.004</pub-id>
<pub-id pub-id-type="pmid">23769623</pub-id></element-citation></ref><ref id="B12-cancers-07-00876"><label>12.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>De Wever</surname><given-names>O.</given-names></name><name><surname>Demetter</surname><given-names>P.</given-names></name><name><surname>Mareel</surname><given-names>M.</given-names></name><name><surname>Bracke</surname><given-names>M.</given-names></name></person-group>
<article-title>Stromal myofibroblasts are drivers of invasive cancer growth</article-title>
<source>Int. J. Cancer</source>
<year>2008</year>
<volume>123</volume>
<fpage>2229</fpage>
<lpage>2238</lpage>
<pub-id pub-id-type="doi">10.1002/ijc.23925</pub-id>
<pub-id pub-id-type="pmid">18777559</pub-id></element-citation></ref><ref id="B13-cancers-07-00876"><label>13.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rasanen</surname><given-names>K.</given-names></name><name><surname>Vaheri</surname><given-names>A.</given-names></name></person-group>
<article-title>Activation of fibroblasts in cancer stroma</article-title>
<source>Exp. Cell Res.</source>
<year>2010</year>
<volume>316</volume>
<fpage>2713</fpage>
<lpage>2722</lpage>
<pub-id pub-id-type="doi">10.1016/j.yexcr.2010.04.032</pub-id>
<pub-id pub-id-type="pmid">20451516</pub-id></element-citation></ref><ref id="B14-cancers-07-00876"><label>14.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Calvo</surname><given-names>F.</given-names></name><name><surname>Sahai</surname><given-names>E.</given-names></name></person-group>
<article-title>Cell communication networks in cancer invasion</article-title>
<source>Curr. Opin. Cell Biol.</source>
<year>2011</year>
<volume>23</volume>
<fpage>621</fpage>
<lpage>629</lpage>
<pub-id pub-id-type="doi">10.1016/j.ceb.2011.04.010</pub-id>
<pub-id pub-id-type="pmid">21570276</pub-id></element-citation></ref><ref id="B15-cancers-07-00876"><label>15.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Karagiannis</surname><given-names>G.S.</given-names></name><name><surname>Poutahidis</surname><given-names>T.</given-names></name><name><surname>Erdman</surname><given-names>S.E.</given-names></name><name><surname>Kirsch</surname><given-names>R.</given-names></name><name><surname>Riddell</surname><given-names>R.H.</given-names></name><name><surname>Diamandis</surname><given-names>E.P.</given-names></name></person-group>
<article-title>Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissue</article-title>
<source>Mol. Cancer Res.</source>
<year>2012</year>
<volume>10</volume>
<fpage>1403</fpage>
<lpage>1418</lpage>
<pub-id pub-id-type="doi">10.1158/1541-7786.MCR-12-0307</pub-id>
<pub-id pub-id-type="pmid">23024188</pub-id></element-citation></ref><ref id="B16-cancers-07-00876"><label>16.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chiang</surname><given-names>A.C.</given-names></name><name><surname>Massague</surname><given-names>J.</given-names></name></person-group>
<article-title>Molecular basis of metastasis</article-title>
<source>N. Engl. J. Med.</source>
<year>2008</year>
<volume>359</volume>
<fpage>2814</fpage>
<lpage>2823</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMra0805239</pub-id>
<pub-id pub-id-type="pmid">19109576</pub-id></element-citation></ref><ref id="B17-cancers-07-00876"><label>17.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Valastyan</surname><given-names>S.</given-names></name><name><surname>Weinberg</surname><given-names>R.A.</given-names></name></person-group>
<article-title>Tumor metastasis: Molecular insights and evolving paradigms</article-title>
<source>Cell</source>
<year>2011</year>
<volume>147</volume>
<fpage>275</fpage>
<lpage>292</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2011.09.024</pub-id>
<pub-id pub-id-type="pmid">22000009</pub-id></element-citation></ref><ref id="B18-cancers-07-00876"><label>18.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kessenbrock</surname><given-names>K.</given-names></name><name><surname>Plaks</surname><given-names>V.</given-names></name><name><surname>Werb</surname><given-names>Z.</given-names></name></person-group>
<article-title>Matrix metalloproteinases: Regulators of the tumor microenvironment</article-title>
<source>Cell</source>
<year>2010</year>
<volume>141</volume>
<fpage>52</fpage>
<lpage>67</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2010.03.015</pub-id>
<pub-id pub-id-type="pmid">20371345</pub-id></element-citation></ref><ref id="B19-cancers-07-00876"><label>19.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Roussos</surname><given-names>E.T.</given-names></name><name><surname>Condeelis</surname><given-names>J.S.</given-names></name><name><surname>Patsialou</surname><given-names>A.</given-names></name></person-group>
<article-title>Chemotaxis in cancer</article-title>
<source>Nat. Rev. Cancer</source>
<year>2011</year>
<volume>11</volume>
<fpage>573</fpage>
<lpage>587</lpage>
<pub-id pub-id-type="doi">10.1038/nrc3078</pub-id>
<pub-id pub-id-type="pmid">21779009</pub-id></element-citation></ref><ref id="B20-cancers-07-00876"><label>20.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yamaguchi</surname><given-names>H.</given-names></name><name><surname>Wyckoff</surname><given-names>J.</given-names></name><name><surname>Condeelis</surname><given-names>J.</given-names></name></person-group>
<article-title>Cell migration in tumors</article-title>
<source>Curr. Opin. Cell Biol.</source>
<year>2005</year>
<volume>17</volume>
<fpage>559</fpage>
<lpage>564</lpage>
<pub-id pub-id-type="doi">10.1016/j.ceb.2005.08.002</pub-id>
<pub-id pub-id-type="pmid">16098726</pub-id></element-citation></ref><ref id="B21-cancers-07-00876"><label>21.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Polyak</surname><given-names>K.</given-names></name><name><surname>Weinberg</surname><given-names>R.A.</given-names></name></person-group>
<article-title>Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits</article-title>
<source>Nat. Rev. Cancer</source>
<year>2009</year>
<volume>9</volume>
<fpage>265</fpage>
<lpage>273</lpage>
<pub-id pub-id-type="doi">10.1038/nrc2620</pub-id>
<pub-id pub-id-type="pmid">19262571</pub-id></element-citation></ref><ref id="B22-cancers-07-00876"><label>22.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cirri</surname><given-names>P.</given-names></name><name><surname>Chiarugi</surname><given-names>P.</given-names></name></person-group>
<article-title>Cancer associated fibroblasts: The dark side of the coin</article-title>
<source>Am. J. Cancer Res.</source>
<year>2011</year>
<volume>1</volume>
<fpage>482</fpage>
<lpage>497</lpage>
<pub-id pub-id-type="pmid">21984967</pub-id></element-citation></ref><ref id="B23-cancers-07-00876"><label>23.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Luga</surname><given-names>V.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Viloria-Petit</surname><given-names>A.M.</given-names></name><name><surname>Ogunjimi</surname><given-names>A.A.</given-names></name><name><surname>Inanlou</surname><given-names>M.R.</given-names></name><name><surname>Chiu</surname><given-names>E.</given-names></name><name><surname>Buchanan</surname><given-names>M.</given-names></name><name><surname>Hosein</surname><given-names>A.N.</given-names></name><name><surname>Basik</surname><given-names>M.</given-names></name><name><surname>Wrana</surname><given-names>J.L.</given-names></name></person-group>
<article-title>Exosomes mediate stromal mobilization of autocrine wnt-pcp signaling in breast cancer cell migration</article-title>
<source>Cell</source>
<year>2012</year>
<volume>151</volume>
<fpage>1542</fpage>
<lpage>1556</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2012.11.024</pub-id>
<pub-id pub-id-type="pmid">23260141</pub-id></element-citation></ref><ref id="B24-cancers-07-00876"><label>24.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shimoda</surname><given-names>M.</given-names></name><name><surname>Principe</surname><given-names>S.</given-names></name><name><surname>Jackson</surname><given-names>H.W.</given-names></name><name><surname>Luga</surname><given-names>V.</given-names></name><name><surname>Fang</surname><given-names>H.</given-names></name><name><surname>Molyneux</surname><given-names>S.D.</given-names></name><name><surname>Shao</surname><given-names>Y.W.</given-names></name><name><surname>Aiken</surname><given-names>A.</given-names></name><name><surname>Waterhouse</surname><given-names>P.D.</given-names></name><name><surname>Karamboulas</surname><given-names>C.</given-names></name><etal/></person-group>
<article-title>Loss of the timp gene family is sufficient for the acquisition of the caf-like cell state</article-title>
<source>Nat. Cell Biol.</source>
<year>2014</year>
<volume>16</volume>
<fpage>889</fpage>
<lpage>901</lpage>
<pub-id pub-id-type="doi">10.1038/ncb3021</pub-id>
<pub-id pub-id-type="pmid">25150980</pub-id></element-citation></ref><ref id="B25-cancers-07-00876"><label>25.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yamaguchi</surname><given-names>H.</given-names></name></person-group>
<article-title>Pathological roles of invadopodia in cancer invasion and metastasis</article-title>
<source>Eur. J. Cell Biol.</source>
<year>2012</year>
<volume>91</volume>
<fpage>902</fpage>
<lpage>907</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejcb.2012.04.005</pub-id>
<pub-id pub-id-type="pmid">22658792</pub-id></element-citation></ref><ref id="B26-cancers-07-00876"><label>26.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Goicoechea</surname><given-names>S.M.</given-names></name><name><surname>Garcia-Mata</surname><given-names>R.</given-names></name><name><surname>Staub</surname><given-names>J.</given-names></name><name><surname>Valdivia</surname><given-names>A.</given-names></name><name><surname>Sharek</surname><given-names>L.</given-names></name><name><surname>McCulloch</surname><given-names>C.G.</given-names></name><name><surname>Hwang</surname><given-names>R.F.</given-names></name><name><surname>Urrutia</surname><given-names>R.</given-names></name><name><surname>Yeh</surname><given-names>J.J.</given-names></name><name><surname>Kim</surname><given-names>H.J.</given-names></name><etal/></person-group>
<article-title>Palladin promotes invasion of pancreatic cancer cells by enhancing invadopodia formation in cancer-associated fibroblasts</article-title>
<source>Oncogene</source>
<year>2014</year>
<volume>33</volume>
<fpage>1265</fpage>
<lpage>1273</lpage>
<pub-id pub-id-type="doi">10.1038/onc.2013.68</pub-id>
<pub-id pub-id-type="pmid">23524582</pub-id></element-citation></ref><ref id="B27-cancers-07-00876"><label>27.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Butcher</surname><given-names>D.T.</given-names></name><name><surname>Alliston</surname><given-names>T.</given-names></name><name><surname>Weaver</surname><given-names>V.M.</given-names></name></person-group>
<article-title>A tense situation: Forcing tumour progression</article-title>
<source>Nat. Rev. Cancer</source>
<year>2009</year>
<volume>9</volume>
<fpage>108</fpage>
<lpage>122</lpage>
<pub-id pub-id-type="doi">10.1038/nrc2544</pub-id>
<pub-id pub-id-type="pmid">19165226</pub-id></element-citation></ref><ref id="B28-cancers-07-00876"><label>28.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kumar</surname><given-names>S.</given-names></name><name><surname>Weaver</surname><given-names>V.M.</given-names></name></person-group>
<article-title>Mechanics, malignancy, and metastasis: The force journey of a tumor cell</article-title>
<source>Cancer Metastasis Rev.</source>
<year>2009</year>
<volume>28</volume>
<fpage>113</fpage>
<lpage>127</lpage>
<pub-id pub-id-type="doi">10.1007/s10555-008-9173-4</pub-id>
<pub-id pub-id-type="pmid">19153673</pub-id></element-citation></ref><ref id="B29-cancers-07-00876"><label>29.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Levental</surname><given-names>K.R.</given-names></name><name><surname>Yu</surname><given-names>H.</given-names></name><name><surname>Kass</surname><given-names>L.</given-names></name><name><surname>Lakins</surname><given-names>J.N.</given-names></name><name><surname>Egeblad</surname><given-names>M.</given-names></name><name><surname>Erler</surname><given-names>J.T.</given-names></name><name><surname>Fong</surname><given-names>S.F.</given-names></name><name><surname>Csiszar</surname><given-names>K.</given-names></name><name><surname>Giaccia</surname><given-names>A.</given-names></name><name><surname>Weninger</surname><given-names>W.</given-names></name><etal/></person-group>
<article-title>Matrix crosslinking forces tumor progression by enhancing integrin signaling</article-title>
<source>Cell</source>
<year>2009</year>
<volume>139</volume>
<fpage>891</fpage>
<lpage>906</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2009.10.027</pub-id>
<pub-id pub-id-type="pmid">19931152</pub-id></element-citation></ref><ref id="B30-cancers-07-00876"><label>30.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Calvo</surname><given-names>F.</given-names></name><name><surname>Ege</surname><given-names>N.</given-names></name><name><surname>Grande-Garcia</surname><given-names>A.</given-names></name><name><surname>Hooper</surname><given-names>S.</given-names></name><name><surname>Jenkins</surname><given-names>R.P.</given-names></name><name><surname>Chaudhry</surname><given-names>S.I.</given-names></name><name><surname>Harrington</surname><given-names>K.</given-names></name><name><surname>Williamson</surname><given-names>P.</given-names></name><name><surname>Moeendarbary</surname><given-names>E.</given-names></name><name><surname>Charras</surname><given-names>G.</given-names></name><etal/></person-group>
<article-title>Mechanotransduction and yap-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts</article-title>
<source>Nat. Cell Biol.</source>
<year>2013</year>
<volume>15</volume>
<fpage>637</fpage>
<lpage>646</lpage>
<pub-id pub-id-type="doi">10.1038/ncb2756</pub-id>
<pub-id pub-id-type="pmid">23708000</pub-id></element-citation></ref><ref id="B31-cancers-07-00876"><label>31.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Goetz</surname><given-names>J.G.</given-names></name><name><surname>Minguet</surname><given-names>S.</given-names></name><name><surname>Navarro-Lerida</surname><given-names>I.</given-names></name><name><surname>Lazcano</surname><given-names>J.J.</given-names></name><name><surname>Samaniego</surname><given-names>R.</given-names></name><name><surname>Calvo</surname><given-names>E.</given-names></name><name><surname>Tello</surname><given-names>M.</given-names></name><name><surname>Osteso-Ibanez</surname><given-names>T.</given-names></name><name><surname>Pellinen</surname><given-names>T.</given-names></name><name><surname>Echarri</surname><given-names>A.</given-names></name><etal/></person-group>
<article-title>Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis</article-title>
<source>Cell</source>
<year>2011</year>
<volume>146</volume>
<fpage>148</fpage>
<lpage>163</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2011.05.040</pub-id>
<pub-id pub-id-type="pmid">21729786</pub-id></element-citation></ref><ref id="B32-cancers-07-00876"><label>32.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gaggioli</surname><given-names>C.</given-names></name><name><surname>Hooper</surname><given-names>S.</given-names></name><name><surname>Hidalgo-Carcedo</surname><given-names>C.</given-names></name><name><surname>Grosse</surname><given-names>R.</given-names></name><name><surname>Marshall</surname><given-names>J.F.</given-names></name><name><surname>Harrington</surname><given-names>K.</given-names></name><name><surname>Sahai</surname><given-names>E.</given-names></name></person-group>
<article-title>Fibroblast-led collective invasion of carcinoma cells with differing roles for rhogtpases in leading and following cells</article-title>
<source>Nat. Cell Biol.</source>
<year>2007</year>
<volume>9</volume>
<fpage>1392</fpage>
<lpage>1400</lpage>
<pub-id pub-id-type="doi">10.1038/ncb1658</pub-id>
<pub-id pub-id-type="pmid">18037882</pub-id></element-citation></ref><ref id="B33-cancers-07-00876"><label>33.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Otomo</surname><given-names>R.</given-names></name><name><surname>Otsubo</surname><given-names>C.</given-names></name><name><surname>Matsushima-Hibiya</surname><given-names>Y.</given-names></name><name><surname>Miyazaki</surname><given-names>M.</given-names></name><name><surname>Tashiro</surname><given-names>F.</given-names></name><name><surname>Ichikawa</surname><given-names>H.</given-names></name><name><surname>Kohno</surname><given-names>T.</given-names></name><name><surname>Ochiya</surname><given-names>T.</given-names></name><name><surname>Yokota</surname><given-names>J.</given-names></name><name><surname>Nakagama</surname><given-names>H.</given-names></name><etal/></person-group>
<article-title>Tspan12 is a critical factor for cancer-fibroblast cell contact-mediated cancer invasion</article-title>
<source>Proc. Natl. Acad. Sci. USA</source>
<year>2014</year>
<volume>111</volume>
<fpage>18691</fpage>
<lpage>18696</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1412062112</pub-id>
<pub-id pub-id-type="pmid">25512506</pub-id></element-citation></ref><ref id="B34-cancers-07-00876"><label>34.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ikeguchi</surname><given-names>M.</given-names></name><name><surname>Miyake</surname><given-names>T.</given-names></name><name><surname>Matsunaga</surname><given-names>T.</given-names></name><name><surname>Yamamoto</surname><given-names>M.</given-names></name><name><surname>Fukumoto</surname><given-names>Y.</given-names></name><name><surname>Yamada</surname><given-names>Y.</given-names></name><name><surname>Fukuda</surname><given-names>K.</given-names></name><name><surname>Saito</surname><given-names>H.</given-names></name><name><surname>Tatebe</surname><given-names>S.</given-names></name><name><surname>Tsujitani</surname><given-names>S.</given-names></name></person-group>
<article-title>Recent results of therapy for scirrhous gastric cancer</article-title>
<source>Surg. Today</source>
<year>2009</year>
<volume>39</volume>
<fpage>290</fpage>
<lpage>294</lpage>
<pub-id pub-id-type="doi">10.1007/s00595-008-3860-1</pub-id>
<pub-id pub-id-type="pmid">19319634</pub-id></element-citation></ref><ref id="B35-cancers-07-00876"><label>35.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Otsuji</surname><given-names>E.</given-names></name><name><surname>Kuriu</surname><given-names>Y.</given-names></name><name><surname>Okamoto</surname><given-names>K.</given-names></name><name><surname>Ochiai</surname><given-names>T.</given-names></name><name><surname>Ichikawa</surname><given-names>D.</given-names></name><name><surname>Hagiwara</surname><given-names>A.</given-names></name><name><surname>Yamagishi</surname><given-names>H.</given-names></name></person-group>
<article-title>Outcome of surgical treatment for patients with scirrhous carcinoma of the stomach</article-title>
<source>Am. J. Surg.</source>
<year>2004</year>
<volume>188</volume>
<fpage>327</fpage>
<lpage>332</lpage>
<pub-id pub-id-type="doi">10.1016/j.amjsurg.2004.06.010</pub-id>
<pub-id pub-id-type="pmid">15450843</pub-id></element-citation></ref><ref id="B36-cancers-07-00876"><label>36.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yashiro</surname><given-names>M.</given-names></name><name><surname>Hirakawa</surname><given-names>K.</given-names></name></person-group>
<article-title>Cancer-stromal interactions in scirrhous gastric carcinoma</article-title>
<source>Cancer Microenviron.</source>
<year>2010</year>
<volume>3</volume>
<fpage>127</fpage>
<lpage>135</lpage>
<pub-id pub-id-type="doi">10.1007/s12307-010-0036-5</pub-id>
<pub-id pub-id-type="pmid">21209779</pub-id></element-citation></ref><ref id="B37-cancers-07-00876"><label>37.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yashiro</surname><given-names>M.</given-names></name><name><surname>Chung</surname><given-names>Y.S.</given-names></name><name><surname>Sowa</surname><given-names>M.</given-names></name></person-group>
<article-title>Role of orthotopic fibroblasts in the development of scirrhous gastric carcinoma</article-title>
<source>Jpn. J. Cancer Res.</source>
<year>1994</year>
<volume>85</volume>
<fpage>883</fpage>
<lpage>886</lpage>
<pub-id pub-id-type="doi">10.1111/j.1349-7006.1994.tb02963.x</pub-id>
<pub-id pub-id-type="pmid">7961114</pub-id></element-citation></ref><ref id="B38-cancers-07-00876"><label>38.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Semba</surname><given-names>S.</given-names></name><name><surname>Kodama</surname><given-names>Y.</given-names></name><name><surname>Ohnuma</surname><given-names>K.</given-names></name><name><surname>Mizuuchi</surname><given-names>E.</given-names></name><name><surname>Masuda</surname><given-names>R.</given-names></name><name><surname>Yashiro</surname><given-names>M.</given-names></name><name><surname>Hirakawa</surname><given-names>K.</given-names></name><name><surname>Yokozaki</surname><given-names>H.</given-names></name></person-group>
<article-title>Direct cancer-stromal interaction increases fibroblast proliferation and enhances invasive properties of scirrhous-type gastric carcinoma cells</article-title>
<source>Br. J. Cancer</source>
<year>2009</year>
<volume>101</volume>
<fpage>1365</fpage>
<lpage>1373</lpage>
<pub-id pub-id-type="doi">10.1038/sj.bjc.6605309</pub-id>
<pub-id pub-id-type="pmid">19773759</pub-id></element-citation></ref><ref id="B39-cancers-07-00876"><label>39.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fuyuhiro</surname><given-names>Y.</given-names></name><name><surname>Yashiro</surname><given-names>M.</given-names></name><name><surname>Noda</surname><given-names>S.</given-names></name><name><surname>Matsuoka</surname><given-names>J.</given-names></name><name><surname>Hasegawa</surname><given-names>T.</given-names></name><name><surname>Kato</surname><given-names>Y.</given-names></name><name><surname>Sawada</surname><given-names>T.</given-names></name><name><surname>Hirakawa</surname><given-names>K.</given-names></name></person-group>
<article-title>Cancer-associated orthotopic myofibroblasts stimulates the motility of gastric carcinoma cells</article-title>
<source>Cancer Sci.</source>
<year>2012</year>
<volume>103</volume>
<fpage>797</fpage>
<lpage>805</lpage>
<pub-id pub-id-type="doi">10.1111/j.1349-7006.2012.02209.x</pub-id>
<pub-id pub-id-type="pmid">22320235</pub-id></element-citation></ref><ref id="B40-cancers-07-00876"><label>40.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Koyama</surname><given-names>T.</given-names></name><name><surname>Yashiro</surname><given-names>M.</given-names></name><name><surname>Inoue</surname><given-names>T.</given-names></name><name><surname>Nishimura</surname><given-names>S.</given-names></name><name><surname>Chung</surname><given-names>K.H.Y.S.</given-names></name></person-group>
<article-title>Tgf-beta1 secreted by gastric fibroblasts up-regulates cd44h expression and stimulates the peritoneal metastatic ability of scirrhous gastric cancer cells</article-title>
<source>Int. J. Oncol.</source>
<year>2000</year>
<volume>16</volume>
<fpage>355</fpage>
<lpage>362</lpage>
<pub-id pub-id-type="doi">10.3892/ijo.16.2.355</pub-id>
<pub-id pub-id-type="pmid">10639581</pub-id></element-citation></ref><ref id="B41-cancers-07-00876"><label>41.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yashiro</surname><given-names>M.</given-names></name><name><surname>Chung</surname><given-names>Y.S.</given-names></name><name><surname>Inoue</surname><given-names>T.</given-names></name><name><surname>Nishimura</surname><given-names>S.</given-names></name><name><surname>Matsuoka</surname><given-names>T.</given-names></name><name><surname>Fujihara</surname><given-names>T.</given-names></name><name><surname>Sowa</surname><given-names>M.</given-names></name></person-group>
<article-title>Hepatocyte growth factor (HGF) produced by peritoneal fibroblasts may affect mesothelial cell morphology and promote peritoneal dissemination</article-title>
<source>Int. J. Cancer</source>
<year>1996</year>
<volume>67</volume>
<fpage>289</fpage>
<lpage>293</lpage>
<pub-id pub-id-type="doi">10.1002/(SICI)1097-0215(19960717)67:2&#x0003c;289::AID-IJC22&#x0003e;3.0.CO;2-5</pub-id>
<pub-id pub-id-type="pmid">8760601</pub-id></element-citation></ref><ref id="B42-cancers-07-00876"><label>42.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yashiro</surname><given-names>M.</given-names></name><name><surname>Chung</surname><given-names>Y.S.</given-names></name><name><surname>Nishimura</surname><given-names>S.</given-names></name><name><surname>Inoue</surname><given-names>T.</given-names></name><name><surname>Sowa</surname><given-names>M.</given-names></name></person-group>
<article-title>Fibrosis in the peritoneum induced by scirrhous gastric cancer cells may act as &#x0201c;soil&#x0201d; for peritoneal dissemination</article-title>
<source>Cancer</source>
<year>1996</year>
<volume>77</volume>
<fpage>1668</fpage>
<lpage>1675</lpage>
<pub-id pub-id-type="doi">10.1002/(SICI)1097-0142(19960415)77:8+&#x0003c;1668::AID-CNCR13&#x0003e;3.0.CO;2-W</pub-id>
<pub-id pub-id-type="pmid">8608560</pub-id></element-citation></ref><ref id="B43-cancers-07-00876"><label>43.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hasegawa</surname><given-names>T.</given-names></name><name><surname>Yashiro</surname><given-names>M.</given-names></name><name><surname>Nishii</surname><given-names>T.</given-names></name><name><surname>Matsuoka</surname><given-names>J.</given-names></name><name><surname>Fuyuhiro</surname><given-names>Y.</given-names></name><name><surname>Morisaki</surname><given-names>T.</given-names></name><name><surname>Fukuoka</surname><given-names>T.</given-names></name><name><surname>Shimizu</surname><given-names>K.</given-names></name><name><surname>Shimizu</surname><given-names>T.</given-names></name><name><surname>Miwa</surname><given-names>A.</given-names></name><etal/></person-group>
<article-title>Cancer-associated fibroblasts might sustain the stemness of scirrhous gastric cancer cells via transforming growth factor-beta signaling</article-title>
<source>Int. J. Cancer</source>
<year>2014</year>
<volume>134</volume>
<fpage>1785</fpage>
<lpage>1795</lpage>
<pub-id pub-id-type="doi">10.1002/ijc.28520</pub-id>
<pub-id pub-id-type="pmid">24155219</pub-id></element-citation></ref><ref id="B44-cancers-07-00876"><label>44.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fuyuhiro</surname><given-names>Y.</given-names></name><name><surname>Yashiro</surname><given-names>M.</given-names></name><name><surname>Noda</surname><given-names>S.</given-names></name><name><surname>Kashiwagi</surname><given-names>S.</given-names></name><name><surname>Matsuoka</surname><given-names>J.</given-names></name><name><surname>Doi</surname><given-names>Y.</given-names></name><name><surname>Kato</surname><given-names>Y.</given-names></name><name><surname>Hasegawa</surname><given-names>T.</given-names></name><name><surname>Sawada</surname><given-names>T.</given-names></name><name><surname>Hirakawa</surname><given-names>K.</given-names></name></person-group>
<article-title>Upregulation of cancer-associated myofibroblasts by TGF-beta from scirrhous gastric carcinoma cells</article-title>
<source>Br. J. Cancer</source>
<year>2011</year>
<volume>105</volume>
<fpage>996</fpage>
<lpage>1001</lpage>
<pub-id pub-id-type="doi">10.1038/bjc.2011.330</pub-id>
<pub-id pub-id-type="pmid">21863023</pub-id></element-citation></ref><ref id="B45-cancers-07-00876"><label>45.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ura</surname><given-names>H.</given-names></name><name><surname>Obara</surname><given-names>T.</given-names></name><name><surname>Yokota</surname><given-names>K.</given-names></name><name><surname>Shibata</surname><given-names>Y.</given-names></name><name><surname>Okamura</surname><given-names>K.</given-names></name><name><surname>Namiki</surname><given-names>M.</given-names></name></person-group>
<article-title>Effects of transforming growth factor-beta released from gastric carcinoma cells on the contraction of collagen-matrix gels containing fibroblasts</article-title>
<source>Cancer Res.</source>
<year>1991</year>
<volume>51</volume>
<fpage>3550</fpage>
<lpage>3554</lpage>
<pub-id pub-id-type="pmid">1647270</pub-id></element-citation></ref><ref id="B46-cancers-07-00876"><label>46.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yamaguchi</surname><given-names>H.</given-names></name><name><surname>Yoshida</surname><given-names>N.</given-names></name><name><surname>Takanashi</surname><given-names>M.</given-names></name><name><surname>Ito</surname><given-names>Y.</given-names></name><name><surname>Fukami</surname><given-names>K.</given-names></name><name><surname>Yanagihara</surname><given-names>K.</given-names></name><name><surname>Yashiro</surname><given-names>M.</given-names></name><name><surname>Sakai</surname><given-names>R.</given-names></name></person-group>
<article-title>Stromal fibroblasts mediate extracellular matrix remodeling and invasion of scirrhous gastric carcinoma cells</article-title>
<source>PLoS ONE</source>
<year>2014</year>
<volume>9</volume>
<fpage>e85485</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0085485</pub-id>
<pub-id pub-id-type="pmid">24427313</pub-id></element-citation></ref><ref id="B47-cancers-07-00876"><label>47.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Satoyoshi</surname><given-names>R.</given-names></name><name><surname>Kuriyama</surname><given-names>S.</given-names></name><name><surname>Aiba</surname><given-names>N.</given-names></name><name><surname>Yashiro</surname><given-names>M.</given-names></name><name><surname>Tanaka</surname><given-names>M.</given-names></name></person-group>
<article-title>Asporin activates coordinated invasion of scirrhous gastric cancer and cancer-associated fibroblasts</article-title>
<source>Oncogene</source>
<year>2015</year>
<volume>34</volume>
<fpage>650</fpage>
<lpage>660</lpage>
<pub-id pub-id-type="doi">10.1038/onc.2013.584</pub-id>
<pub-id pub-id-type="pmid">24441039</pub-id></element-citation></ref><ref id="B48-cancers-07-00876"><label>48.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Choe</surname><given-names>C.</given-names></name><name><surname>Shin</surname><given-names>Y.S.</given-names></name><name><surname>Kim</surname><given-names>S.H.</given-names></name><name><surname>Jeon</surname><given-names>M.J.</given-names></name><name><surname>Choi</surname><given-names>S.J.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name></person-group>
<article-title>Tumor-stromal interactions with direct cell contacts enhance motility of non-small cell lung cancer cells through the hedgehog signaling pathway</article-title>
<source>Anticancer Res.</source>
<year>2013</year>
<volume>33</volume>
<fpage>3715</fpage>
<lpage>3723</lpage>
<pub-id pub-id-type="pmid">24023301</pub-id></element-citation></ref><ref id="B49-cancers-07-00876"><label>49.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Camp</surname><given-names>J.T.</given-names></name><name><surname>Elloumi</surname><given-names>F.</given-names></name><name><surname>Roman-Perez</surname><given-names>E.</given-names></name><name><surname>Rein</surname><given-names>J.</given-names></name><name><surname>Stewart</surname><given-names>D.A.</given-names></name><name><surname>Harrell</surname><given-names>J.C.</given-names></name><name><surname>Perou</surname><given-names>C.M.</given-names></name><name><surname>Troester</surname><given-names>M.A.</given-names></name></person-group>
<article-title>Interactions with fibroblasts are distinct in basal-like and luminal breast cancers</article-title>
<source>Mol. Cancer Res.</source>
<year>2011</year>
<volume>9</volume>
<fpage>3</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="doi">10.1158/1541-7786.MCR-10-0372</pub-id>
<pub-id pub-id-type="pmid">21131600</pub-id></element-citation></ref><ref id="B50-cancers-07-00876"><label>50.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kinugasa</surname><given-names>Y.</given-names></name><name><surname>Matsui</surname><given-names>T.</given-names></name><name><surname>Takakura</surname><given-names>N.</given-names></name></person-group>
<article-title>CD44 expressed on cancer-associated fibroblasts is a functional molecule supporting the stemness and drug resistance of malignant cancer cells in the tumor microenvironment</article-title>
<source>Stem Cells</source>
<year>2014</year>
<volume>32</volume>
<fpage>145</fpage>
<fpage>156</fpage>
<pub-id pub-id-type="doi">10.1002/stem.1556</pub-id>
<pub-id pub-id-type="pmid">24395741</pub-id></element-citation></ref><ref id="B51-cancers-07-00876"><label>51.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stuelten</surname><given-names>C.H.</given-names></name><name><surname>Busch</surname><given-names>J.I.</given-names></name><name><surname>Tang</surname><given-names>B.</given-names></name><name><surname>Flanders</surname><given-names>K.C.</given-names></name><name><surname>Oshima</surname><given-names>A.</given-names></name><name><surname>Sutton</surname><given-names>E.</given-names></name><name><surname>Karpova</surname><given-names>T.S.</given-names></name><name><surname>Roberts</surname><given-names>A.B.</given-names></name><name><surname>Wakefield</surname><given-names>L.M.</given-names></name><name><surname>Niederhuber</surname><given-names>J.E.</given-names></name></person-group>
<article-title>Transient tumor-fibroblast interactions increase tumor cell malignancy by a TGF-beta mediated mechanism in a mouse xenograft model of breast cancer</article-title>
<source>PLoS ONE</source>
<year>2010</year>
<volume>5</volume>
<fpage>e9832</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0009832</pub-id>
<pub-id pub-id-type="pmid">20352126</pub-id></element-citation></ref><ref id="B52-cancers-07-00876"><label>52.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Togo</surname><given-names>S.</given-names></name><name><surname>Polanska</surname><given-names>U.M.</given-names></name><name><surname>Horimoto</surname><given-names>Y.</given-names></name><name><surname>Orimo</surname><given-names>A.</given-names></name></person-group>
<article-title>Carcinoma-associated fibroblasts are a promising therapeutic target</article-title>
<source>Cancers</source>
<year>2013</year>
<volume>5</volume>
<fpage>149</fpage>
<lpage>169</lpage>
<pub-id pub-id-type="doi">10.3390/cancers5010149</pub-id>
<pub-id pub-id-type="pmid">24216702</pub-id></element-citation></ref><ref id="B53-cancers-07-00876"><label>53.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gonda</surname><given-names>T.A.</given-names></name><name><surname>Varro</surname><given-names>A.</given-names></name><name><surname>Wang</surname><given-names>T.C.</given-names></name><name><surname>Tycko</surname><given-names>B.</given-names></name></person-group>
<article-title>Molecular biology of cancer-associated fibroblasts: Can these cells be targeted in anti-cancer therapy?</article-title>
<source>Semin. Cell Dev. Biol.</source>
<year>2010</year>
<volume>21</volume>
<fpage>2</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="doi">10.1016/j.semcdb.2009.10.001</pub-id>
<pub-id pub-id-type="pmid">19840860</pub-id></element-citation></ref><ref id="B54-cancers-07-00876"><label>54.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kraman</surname><given-names>M.</given-names></name><name><surname>Bambrough</surname><given-names>P.J.</given-names></name><name><surname>Arnold</surname><given-names>J.N.</given-names></name><name><surname>Roberts</surname><given-names>E.W.</given-names></name><name><surname>Magiera</surname><given-names>L.</given-names></name><name><surname>Jones</surname><given-names>J.O.</given-names></name><name><surname>Gopinathan</surname><given-names>A.</given-names></name><name><surname>Tuveson</surname><given-names>D.A.</given-names></name><name><surname>Fearon</surname><given-names>D.T.</given-names></name></person-group>
<article-title>Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha</article-title>
<source>Science</source>
<year>2010</year>
<volume>330</volume>
<fpage>827</fpage>
<lpage>830</lpage>
<pub-id pub-id-type="doi">10.1126/science.1195300</pub-id>
<pub-id pub-id-type="pmid">21051638</pub-id></element-citation></ref><ref id="B55-cancers-07-00876"><label>55.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tendo</surname><given-names>M.</given-names></name><name><surname>Yashiro</surname><given-names>M.</given-names></name><name><surname>Nakazawa</surname><given-names>K.</given-names></name><name><surname>Yamada</surname><given-names>N.</given-names></name><name><surname>Hirakawa</surname><given-names>K.</given-names></name></person-group>
<article-title>Inhibitory effect of a selective cyclooxygenase inhibitor on the invasion-stimulating activity of orthotopic fibroblasts for scirrhous gastric cancer cells</article-title>
<source>Cancer Sci.</source>
<year>2005</year>
<volume>96</volume>
<fpage>451</fpage>
<lpage>455</lpage>
<pub-id pub-id-type="doi">10.1111/j.1349-7006.2005.00066.x</pub-id>
<pub-id pub-id-type="pmid">16053517</pub-id></element-citation></ref><ref id="B56-cancers-07-00876"><label>56.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hooper</surname><given-names>S.</given-names></name><name><surname>Gaggioli</surname><given-names>C.</given-names></name><name><surname>Sahai</surname><given-names>E.</given-names></name></person-group>
<article-title>A chemical biology screen reveals a role for rab21-mediated control of actomyosin contractility in fibroblast-driven cancer invasion</article-title>
<source>Br. J. Cancer</source>
<year>2010</year>
<volume>102</volume>
<fpage>392</fpage>
<lpage>402</lpage>
<pub-id pub-id-type="doi">10.1038/sj.bjc.6605469</pub-id>
<pub-id pub-id-type="pmid">19953096</pub-id></element-citation></ref><ref id="B57-cancers-07-00876"><label>57.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ozdemir</surname><given-names>B.C.</given-names></name><name><surname>Pentcheva-Hoang</surname><given-names>T.</given-names></name><name><surname>Carstens</surname><given-names>J.L.</given-names></name><name><surname>Zheng</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>C.C.</given-names></name><name><surname>Simpson</surname><given-names>T.R.</given-names></name><name><surname>Laklai</surname><given-names>H.</given-names></name><name><surname>Sugimoto</surname><given-names>H.</given-names></name><name><surname>Kahlert</surname><given-names>C.</given-names></name><name><surname>Novitskiy</surname><given-names>S.V.</given-names></name><etal/></person-group>
<article-title>Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival</article-title>
<source>Cancer Cell</source>
<year>2014</year>
<volume>25</volume>
<fpage>719</fpage>
<lpage>734</lpage>
<pub-id pub-id-type="doi">10.1016/j.ccr.2014.04.005</pub-id>
<pub-id pub-id-type="pmid">24856586</pub-id></element-citation></ref><ref id="B58-cancers-07-00876"><label>58.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rhim</surname><given-names>A.D.</given-names></name><name><surname>Oberstein</surname><given-names>P.E.</given-names></name><name><surname>Thomas</surname><given-names>D.H.</given-names></name><name><surname>Mirek</surname><given-names>E.T.</given-names></name><name><surname>Palermo</surname><given-names>C.F.</given-names></name><name><surname>Sastra</surname><given-names>S.A.</given-names></name><name><surname>Dekleva</surname><given-names>E.N.</given-names></name><name><surname>Saunders</surname><given-names>T.</given-names></name><name><surname>Becerra</surname><given-names>C.P.</given-names></name><name><surname>Tattersall</surname><given-names>I.W.</given-names></name><etal/></person-group>
<article-title>Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma</article-title>
<source>Cancer Cell</source>
<year>2014</year>
<volume>25</volume>
<fpage>735</fpage>
<lpage>747</lpage>
<pub-id pub-id-type="doi">10.1016/j.ccr.2014.04.021</pub-id>
<pub-id pub-id-type="pmid">24856585</pub-id></element-citation></ref><ref id="B59-cancers-07-00876"><label>59.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Loeffler</surname><given-names>M.</given-names></name><name><surname>Kruger</surname><given-names>J.A.</given-names></name><name><surname>Niethammer</surname><given-names>A.G.</given-names></name><name><surname>Reisfeld</surname><given-names>R.A.</given-names></name></person-group>
<article-title>Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake</article-title>
<source>J. Clin. Investig.</source>
<year>2006</year>
<volume>116</volume>
<fpage>1955</fpage>
<lpage>1962</lpage>
<pub-id pub-id-type="doi">10.1172/JCI26532</pub-id>
<pub-id pub-id-type="pmid">16794736</pub-id></element-citation></ref><ref id="B60-cancers-07-00876"><label>60.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Olive</surname><given-names>K.P.</given-names></name><name><surname>Jacobetz</surname><given-names>M.A.</given-names></name><name><surname>Davidson</surname><given-names>C.J.</given-names></name><name><surname>Gopinathan</surname><given-names>A.</given-names></name><name><surname>McIntyre</surname><given-names>D.</given-names></name><name><surname>Honess</surname><given-names>D.</given-names></name><name><surname>Madhu</surname><given-names>B.</given-names></name><name><surname>Goldgraben</surname><given-names>M.A.</given-names></name><name><surname>Caldwell</surname><given-names>M.E.</given-names></name><name><surname>Allard</surname><given-names>D.</given-names></name><etal/></person-group>
<article-title>Inhibition of hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer</article-title>
<source>Science</source>
<year>2009</year>
<volume>324</volume>
<fpage>1457</fpage>
<lpage>1461</lpage>
<pub-id pub-id-type="pmid">19460966</pub-id></element-citation></ref></ref-list></back></article>